A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy

British Journal of Dermatology

Volumn 163, Issue 4, 2010, Pages 870-874

  Gelanew, T ^a,b   Amogne, W ^b   Abebe, T ^b   Kuhls, K ^a   Hailu, A ^b   Schonian G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

human immunodeficiency virus (HIV); immune reconstitution inflammatory syndrome; Leishmania donovani; post kala azar dermal leishmaniasis; ribosomal DNA internal transcribed spacer 1; visceral leishmaniasis

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ; HEAT SHOCK PROTEIN 70; INTERNAL TRANSCRIBED SPACER 1; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MEGLUMINE ANTIMONATE; RIBOSOME DNA; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; ETHIOPIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEISHMANIA DONOVANI; MACULOPAPULAR RASH; MALE; NUCLEOTIDE SEQUENCE; PARA KALA AZAR DERMAL LEISHMANIASIS; PARASITE ISOLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN DEFECT; SKIN LEISHMANIASIS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; DNA, PROTOZOAN; DNA, RIBOSOMAL SPACER; HIV INFECTIONS; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

EID: 77957101081     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09768.x     Document Type: Article

References (19)

1. Zijlstra EE, Musa AM, Khalil EA et al. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 2003 3 : 87 98.
2. Hailu A, Zewde A, Desta Y. A case of PKDL with no previous history of visceral leishmaniasis. J Ethiop Med Pract 2001 3 : 93 5.
3. Antinori S, Longhi E, Bestetti G et al. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome. Br J Dermatol 2007 157 : 1032 1036.
4. Ramos A, Cruz I, Munez E et al. Post-kala-azar dermal leishmaniasis and uveitis in an HIV-positive patient. Infection 2008 36 : 184 186.
5. Ridolfo AL, Gervasoni C, Antinori S et al. Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum. J Infect 2000 40 : 199 202.
6. Stark D, Pett S, Marriott D, Harkness J. Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient. J Clin Microbiol 2006 44 : 1178 1180.
7. Ritmeijer K, Veeken H, Melaku Y et al. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg 2001 95 : 668 672.
8. Gilad J, Borer A, Hallel-Halevy D et al. Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection. Isr Med Assoc J 2001 3 : 451 452.
9. Belay AD, Asafa Y, Mesure J, Davidson RN. Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy. Ann Trop Med Parasitol 2006 100 : 223 227.
10. Schönian G, Nasereddin A, Dinse N et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 2003 47 : 349 358.
11. Thompson JD, Higgins DG, Gibson TJ. Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994 22 : 4673 4680.
12. Garcia L, Kindt A, Bermudez H et al. Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes. J Clin Microbiol 2004 42 : 2294 2297.
13. Blanche P, Gombert B, Rivoal O et al. Uveitis due to Leishmania major as part of HAART-induced immune restitution syndrome in a patient with AIDS. Clin Infect Dis 2002 34 : 1279 1280.
14. Jamjoom MB, Ashford RW, Bates PA et al. Leishmania donovani is the only cause of visceral leishmaniasis in East Africa; previous descriptions of L. infantum and 'L. archibaldi' from this region are a consequence of convergent evolution in the isoenzyme data. Parasitology 2004 129 : 399 409.
15. Schönian G, Schnur L, el Fari M et al. Genetic heterogeneity in the species Leishmania tropica revealed by different PCR-based methods. Trans R Soc Trop Med Hyg 2001 95 : 217 224.
16. Harris DJ, Crandall KA. Intragenomic variation within ITS1 and ITS2 of freshwater crayfishes (Decapoda: Cambaridae): implications for phylogenetic and microsatellite studies. Mol Biol Evol 2000 17 : 284 291.
17. Wörheide G, Nichols SA, Goldberg J. Intragenomic variation of the rDNA internal transcribed spacers in sponges (Phylum Porifera): implications for phylogenetic studies. Mol Phylogenet Evol 2004 33 : 816 830.
18. Ratnam I, Chiu C, Kandala NB et al. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006 42 : 418 427.
19. Shelburne SA, Visnegarwala F, Darcourt J et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005 19 : 399 406.